Placebo matching BLU-808, tablet, BLU-808, BLU-808
BLU-808-1201
Phase 2 small_molecule active
Quick answer
Placebo matching BLU-808, tablet, BLU-808, BLU-808 for Chronic Inducible Urticaria and Chronic Spontaneous Urticaria is a Phase 2 program (small_molecule) at Blueprint Medicines (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blueprint Medicines (Netherlands) B.V.
- Indication
- Chronic Inducible Urticaria and Chronic Spontaneous Urticaria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active